Double maintains 1 strategies that include NVS - Novartis AG
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 71.56% | $590.55M | 0.36% |
EWL | 70.24% | $1.30B | 0.5% |
IXJ | 67.33% | $3.72B | 0.41% |
EFAV | 63.15% | $5.40B | 0.2% |
HDEF | 61.60% | $2.00B | 0.09% |
ACWV | 61.07% | $3.30B | 0.2% |
KXI | 60.57% | $847.40M | 0.41% |
DWX | 60.20% | $476.74M | 0.45% |
GCOW | 59.37% | $2.30B | 0.6% |
XLV | 59.12% | $34.14B | 0.09% |
SCHY | 59.05% | $1.17B | 0.08% |
NFRA | 58.34% | $2.71B | 0.47% |
IYH | 58.12% | $2.71B | 0.39% |
FICS | 57.83% | $220.89M | 0.7% |
EWU | 57.58% | $3.01B | 0.5% |
VHT | 57.31% | $15.31B | 0.09% |
FHLC | 57.16% | $2.42B | 0.084% |
IYK | 56.75% | $1.44B | 0.4% |
IDLV | 56.47% | $394.19M | 0.25% |
IHE | 56.32% | $557.07M | 0.39% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UNG | -0.03% | $359.91M | 1.06% |
SGOV | -0.14% | $49.84B | 0.09% |
GBIL | 0.57% | $6.40B | 0.12% |
SHYM | 0.62% | $349.95M | 0.35% |
BKCH | -0.63% | $168.58M | 0.5% |
MAGS | -0.66% | $2.35B | 0.29% |
CRPT | -0.67% | $138.36M | 0.85% |
XHLF | 0.70% | $1.73B | 0.03% |
DBC | 1.20% | $1.21B | 0.87% |
CONY | -1.31% | $1.49B | 1.22% |
FTSD | -1.33% | $231.79M | 0.25% |
PDBC | 1.37% | $4.37B | 0.59% |
DAPP | -1.40% | $215.54M | 0.51% |
BITQ | -1.41% | $221.66M | 0.85% |
WEAT | 1.57% | $117.15M | 0.28% |
SATO | -1.58% | $10.90M | 0.6% |
BILZ | 1.61% | $827.49M | 0.14% |
ARKW | 1.64% | $2.10B | 0.82% |
FBY | -1.78% | $175.97M | 1.06% |
CANE | -1.81% | $10.44M | 0.29% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GSK | 65.11% | $78.10B | +0.21% | 4.17% |
AZN | 62.59% | $216.63B | -10.44% | 2.22% |
JNJ | 55.87% | $366.71B | +4.28% | 3.30% |
NGG | 55.16% | $72.07B | +29.44% | 4.20% |
PFE | 54.38% | $137.53B | -13.55% | 7.04% |
UL | 54.35% | $149.53B | +10.78% | 3.18% |
HLN | 52.82% | $46.67B | +25.67% | 1.71% |
ABT | 52.41% | $233.80B | +29.32% | 1.70% |
KO | 52.38% | $302.72B | +10.49% | 2.83% |
AMGN | 48.49% | $149.01B | -11.30% | 3.34% |
TAK | 48.31% | $47.52B | +16.69% | 4.33% |
AEP | 48.19% | $54.73B | +16.78% | 3.58% |
SO | 48.18% | $99.90B | +17.18% | 3.20% |
O | 47.76% | $51.50B | +7.97% | 5.59% |
DTE | 47.64% | $27.31B | +18.57% | 3.27% |
ES | 47.61% | $23.28B | +11.73% | 4.65% |
ATO | 47.41% | $24.22B | +30.72% | 2.24% |
DUK | 47.29% | $90.88B | +16.65% | 3.59% |
PPL | 47.28% | $24.81B | +21.37% | 3.18% |
MMC | 47.26% | $106.91B | +2.97% | 1.50% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -27.84% | $162.92M | 0.5% |
UUP | -27.22% | $237.02M | 0.77% |
VIXY | -21.30% | $165.69M | 0.85% |
TAIL | -19.72% | $99.76M | 0.59% |
TPMN | -9.98% | $30.77M | 0.65% |
CLIP | -9.25% | $1.52B | 0.07% |
TESL | -8.27% | $32.78M | 1.2% |
EETH | -8.22% | $56.79M | 0.95% |
KCCA | -7.77% | $104.88M | 0.87% |
BTF | -7.30% | $31.40M | 1.25% |
CETH | -7.01% | $21.77M | 0% |
FETH | -6.97% | $1.16B | 0.25% |
ETHV | -6.89% | $115.72M | 0% |
ETHA | -6.84% | $4.24B | 0.25% |
QETH | -6.80% | $22.19M | 0.25% |
ETH | -6.78% | $1.30B | 0% |
EZET | -6.78% | $34.20M | 0% |
ETHE | -6.65% | $2.77B | 2.5% |
ETHW | -6.58% | $260.18M | 0% |
UGA | -5.47% | $72.51M | 0.97% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AIFU | -15.09% | $6.13B | +82.50% | 0.00% |
DFDV | -14.15% | $247.94M | +1,821.34% | 0.00% |
STRL | -12.14% | $7.04B | +95.63% | 0.00% |
TLN | -11.52% | $13.56B | +168.31% | 0.00% |
ALAB | -10.85% | $15.01B | +50.42% | 0.00% |
RDDT | -10.58% | $26.39B | +123.84% | 0.00% |
MYRG | -10.53% | $2.83B | +34.56% | 0.00% |
ANF | -10.17% | $3.94B | -53.49% | 0.00% |
CCRN | -10.14% | $419.30M | -7.59% | 0.00% |
FVRR | -9.38% | $1.03B | +22.24% | 0.00% |
LITB | -9.13% | $21.70M | -78.27% | 0.00% |
CEG | -8.31% | $100.35B | +59.87% | 0.46% |
LITE | -7.71% | $6.58B | +86.08% | 0.00% |
REAL | -7.48% | $553.03M | +53.29% | 0.00% |
LMB | -7.06% | $1.62B | +144.84% | 0.00% |
PRIM | -6.94% | $4.32B | +60.45% | 0.36% |
MRVL | -6.84% | $66.53B | +10.39% | 0.31% |
FIX | -6.79% | $18.87B | +75.92% | 0.28% |
SMCI | -6.74% | $28.40B | -41.93% | 0.00% |
VRT | -6.66% | $48.46B | +46.89% | 0.11% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GAP | -0.01% | $8.17B | -8.33% | 2.80% |
ALLT | -0.01% | $317.56M | +244.40% | 0.00% |
ZVIA | 0.03% | $240.48M | +439.10% | 0.00% |
RDUS | -0.05% | $835.91M | +94.11% | 2.53% |
LU | 0.06% | $2.30B | +15.61% | 0.00% |
GPI | 0.09% | $5.67B | +47.57% | 0.44% |
SKYT | 0.09% | $475.09M | +29.28% | 0.00% |
ONTO | 0.09% | $4.83B | -54.96% | 0.00% |
BHE | -0.15% | $1.42B | -0.46% | 1.72% |
SSP | 0.15% | $244.71M | -11.15% | 0.00% |
CIG.C | -0.16% | $2.64B | +19.84% | 0.00% |
PAYO | -0.16% | $2.40B | +19.68% | 0.00% |
PCT | -0.19% | $2.46B | +131.42% | 0.00% |
RVLV | 0.20% | $1.49B | +31.36% | 0.00% |
BAND | -0.20% | $453.88M | -9.66% | 0.00% |
EVGO | 0.21% | $499.11M | +51.84% | 0.00% |
META | 0.22% | $1.84T | +45.50% | 0.28% |
PODD | -0.23% | $22.03B | +55.14% | 0.00% |
BFH | 0.25% | $2.65B | +27.60% | 1.46% |
ALNT | 0.25% | $608.09M | +42.14% | 0.33% |
SeekingAlpha
Merck remains a top Big Pharma name with strong leadership, rising sales, and high margins, despite regulatory fears and pressures. Learn why MRK stock is a buy.
Yahoo
Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics. Following the acquisition, the shares of Regulus ceased trading on the NASDAQ exchange, and the company became a fully owned subsidiary of Novartis. The acquisition marks a […]
Yahoo
TEM is scaling fast; Data and Services revenues soar 43%, fueled by big-name pharma and AI model deals.
Yahoo
Incyte stock popped Thursday after the company's board appointed Bill Meury as its new CEO, replacing Herve Hoppenot, who is retiring.
Yahoo
Bill Meury, who shepherded Karuna and Anthos to multibillion-dollar buyouts, will take over Incyte, a successful drug developer now at a crossroads.
Yahoo
Subjects received subcutaneous doses of either 150mg or 300mg every four weeks over a 24-week period.
Current Value
$120.121 Year Return
Current Value
$120.121 Year Return